Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $48.7B |
| FY2017, ended Dec 31, 2017 | $48.5B |
| FY2018, ended Dec 31, 2018 | $45.4B |
| FY2019, ended Dec 31, 2019 | $67.2B |
| FY2020, ended Dec 31, 2020 | $64.9B |
| FY2021, ended Dec 31, 2021 | $72.7B |
| FY2022, ended Dec 31, 2022 | $77.8B |
| FY2023, ended Dec 31, 2023 | $76.5B |
| FY2024, ended Dec 31, 2024 | $90.3B |
| FY2025, ended Dec 31, 2025 | $97.6B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $109B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $19.9B |
| FY2017, ended Dec 31, 2017 | $23.0B |
| FY2018, ended Dec 31, 2018 | $25.2B |
| FY2019, ended Dec 31, 2019 | $22.6B |
| FY2020, ended Dec 31, 2020 | $21.1B |
| FY2021, ended Dec 31, 2021 | $23.5B |
| FY2022, ended Dec 31, 2022 | $29.3B |
| FY2023, ended Dec 31, 2023 | $25.3B |
| FY2024, ended Dec 31, 2024 | $26.8B |
| FY2025, ended Dec 31, 2025 | $29.6B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $30.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.45B | −$2.42B |
| FY2017, ended Dec 31, 2017 | $842M | −$1.03B |
| FY2018, ended Dec 31, 2018 | $2.23B | −$1.06B |
| FY2019, ended Dec 31, 2019 | $4.74B | −$1.77B |
| FY2020, ended Dec 31, 2020 | $3.12B | −$826M |
| FY2021, ended Dec 31, 2021 | $2.39B | −$1.42B |
| FY2022, ended Dec 31, 2022 | $3.52B | −$1.62B |
| FY2023, ended Dec 31, 2023 | $3.98B | −$1.54B |
| FY2024, ended Dec 31, 2024 | $4.40B | $833M |
| FY2025, ended Dec 31, 2025 | $4.34B | −$2.94B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $4.36B | −$3.47B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.98B |
| FY2017, ended Dec 31, 2017 | $2.13B |
| FY2018, ended Dec 31, 2018 | $1.40B |
| FY2019, ended Dec 31, 2019 | $1.98B |
| FY2020, ended Dec 31, 2020 | $1.06B |
| FY2021, ended Dec 31, 2021 | $1.80B |
| FY2022, ended Dec 31, 2022 | $1.92B |
| FY2023, ended Dec 31, 2023 | $748M |
| FY2024, ended Dec 31, 2024 | $1.07B |
| FY2025, ended Dec 31, 2025 | $1.64B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $981M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $47.5B |
| FY2017, ended Dec 31, 2017 | $50.8B |
| FY2018, ended Dec 31, 2018 | $46.8B |
| FY2019, ended Dec 31, 2019 | $46.8B |
| FY2020, ended Dec 31, 2020 | $49.2B |
| FY2021, ended Dec 31, 2021 | $53.7B |
| FY2022, ended Dec 31, 2022 | $57.5B |
| FY2023, ended Dec 31, 2023 | $62.0B |
| FY2024, ended Dec 31, 2024 | $64.8B |
| FY2025, ended Dec 31, 2025 | $72.6B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $74.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 13.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 991M |
| FY2017, ended Dec 31, 2017 | 1.01B |
| FY2018, ended Dec 31, 2018 | 1.03B |
| FY2019, ended Dec 31, 2019 | 1.05B |
| FY2020, ended Dec 31, 2020 | 1.06B |
| FY2021, ended Dec 31, 2021 | 1.06B |
| FY2022, ended Dec 31, 2022 | 1.09B |
| FY2023, ended Dec 31, 2023 | 1.09B |
| FY2024, ended Dec 31, 2024 | 1.10B |
| FY2025, ended Dec 31, 2025 | 1.12B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 1.13B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $3.00M | $3.76B |
| FY2017, ended Dec 31, 2017 | $0 | — | $793M |
| FY2018, ended Dec 31, 2018 | — | — | $1.09B |
| FY2019, ended Dec 31, 2019 | — | — | $844M |
| FY2020, ended Dec 31, 2020 | — | — | $74.0M |
| FY2021, ended Dec 31, 2021 | — | — | $73.0M |
| FY2022, ended Dec 31, 2022 | — | — | $1.81B |
| FY2023, ended Dec 31, 2023 | — | — | $36.0M |
| FY2024, ended Dec 31, 2024 | — | — | $143M |
| FY2025, ended Dec 31, 2025 | — | — | $1.62B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | — | — | $2.13B |
Valuation
At current price- Market Cap
- $104B
- P/E
- 23.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.5×
- Price / Book
- 2.6×
- EV / EBITDA
- 13.2×
Growth
Trailing 12 months- Revenue (TTM)
- $30.2B
- Revenue Growth YoY
- 8.3%
- Revenue CAGR 3Y
- 0.3%
- Revenue CAGR 5Y
- 7.0%
- EPS Growth YoY
- −6.2%
- Net Income Growth YoY
- −5.3%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 24.2%
- Net Margin
- 14.5%
- FCF Margin
- −11.5%
- Return on Equity
- 11.3%
Earnings
Trailing 12 months- Net Income
- $4.36B
- EPS (diluted)
- $3.91
- EBITDA
- $13.5B
- Operating Income
- $7.29B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $981M
- Total Debt
- $74.5B
- Net Debt
- $73.5B
- Total Assets
- $157B
- Total Liabilities
- $117B
- Shareholders' Equity
- $39.9B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $9.78B
- Capital Expenditure
- $13.2B
- Free Cash Flow
- −$3.47B
Dividends and risk
Last 12 months- Dividend Yield
- 3.2%
- Dividend / Share
- $3.00
- Beta (5Y)
- 0.31
Every ratio is calculated from the company’s reported figures.